Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

'Challenging discussions' ahead as 2022/23 pharmacy funding talks start, PSNC says

The Pharmaceutical Services Negotiating Committee (PSNC) expects funding discussions for the fourth year of the five-year pharmacy contract to be “very challenging”, it has said as negotiations officially begin.

Formal negotiations for the 2022/23 pharmacy contract for England have begun ahead of the start of the financial year, although slightly later than planned due to the volume of recent urgent COVID-19 work, PSNC explained in an update this afternoon (February 25).

"The discussions will cover all service, funding and other arrangements for pharmacies in 2022/23, in line with the five-year Community Pharmacy Contractual Framework (CPCF)," PSNC added.

The talks will take into account progress made to date, as well as the outcomes of the annual review revealed last month in which PSNC raised "serious concerns around the capacity available within community pharmacy, and the sector’s funding".

 

PSNC must make "strong case" for funding

 

PSNC vice-chair and contractor Bharat Patel commented: "As we approach the end of year three of the five-year CPCF arrangements, many contractors find themselves in an extremely difficult situation trying to balance spiralling costs, capacity pressures and the increasing workforce issues.

"Some of the immediate pressures of COVID-19 may appear to have gone away, but like most of the health service, pharmacies are not feeling any relief."

PSNC shares the same ambition as the government and NHS England and NHS Improvement "to continue to embed community pharmacies within the wider NHS" and "keep expanding the sector’s role and show the very great value that pharmacies offer", Mr Patel added.

"But this must be balanced with what is reasonable... we must continue to make a strong case for investment in the sector, and to seek fair funding for the walk-in advice that so many people are relying on from pharmacies.

"We are actively gathering evidence as we begin what we expect, once again, to be very challenging discussions,” he concluded.

Topics

         
Pharmacy Manager
Guernsey
£70,000

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD135937

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel